BiotechTube
Home/Theravance Biopharma/Rhonda F. Farnum
RF

Rhonda F. Farnum

Senior Vice President, Commercial and Medical Affairs and Chief Business Officer

Theravance Biopharma

Therapeutic Areas

RespiratoryChronic Obstructive Pulmonary Disease (COPD)

Theravance Biopharma Pipeline

DrugIndicationPhase
YUPELRI® (revefenacin)COPD (Maintenance Treatment)Approved
Nebulized LAMA/LABA Combination (TD-0903)COPD (Maintenance Treatment)Phase 2
JNJ-64417161 (TD-8236)Undisclosed Inflammatory DiseaseOut-licensed

Leadership Team at Theravance Biopharma

RE
Rick E Winningham
Chief Executive Officer
BG
Brett Grimaud
Senior Vice President, General Counsel and Secretary
LS
Laurie Smaldone Alsup
Director
View full Theravance Biopharma profile